Winton Group LTD Bio Techne Corp Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$456.15 - $525.06 $1.11 Million - $1.28 Million	-2,443 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$444.87 - $538.88 $625,487 - $757,665	1,406 Added 135.58%	2,443 $1.18 Million
Q2 2021 Aug 10, 2021	SELL	$387.35 - $450.26 $890,517 - $1.04 Million	-2,299 Reduced 68.91%	1,037 $467,000
Q1 2021 Jul 21, 2021	SELL	$314.62 - $411.0 $559,394 - $730,758	-1,778 Reduced 34.77%	3,336 $1.27 Million
Q4 2020 Feb 12, 2021	SELL	$246.9 - $321.87 $1.99 Million - $2.59 Million	-8,046 Reduced 61.14%	5,114 $1.62 Million
Q3 2020 Oct 30, 2020	SELL	$232.22 - $282.96 $232,220 - $282,960	-1,000 Reduced 7.06%	13,160 $3.26 Million
Q2 2020 Aug 05, 2020	BUY	$185.43 - $279.56 $2.63 Million - $3.96 Million	14,160 New	14,160 $3.74 Million
Q1 2020 May 11, 2020	SELL	$161.17 - $221.51 $2.23 Million - $3.06 Million	-13,808 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$189.68 - $222.09 $2.62 Million - $3.07 Million	13,808 New	13,808 $3.03 Million

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.89B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.